Rapid DiagnosticsMedMira develops, manufactures and markets a range of rapid diagnostic tests that are critical tools in preventing and controlling some of today's greatest healthcare challenges, including infectious diseases like HIV and Hepatitis. Built on the Company’s patented Rapid Flow-Through Technology (RFT) platform, MedMira’s rapid tests have achieved “gold standard” regulatory approvals in the most stringently regulated markets around the world, demonstrating quality and performance time and again. Unique to MedMira’s rapid tests is the ability to deliver multiple results on a single test cartridge using a single drop of specimen for human disease detection. Driven by our goal to improve healthcare through advanced rapid diagnostics we are continuously evolving our product engine and creating new rapid tests for infectious diseases, sexually transmitted diseases, and conditions such as cancer and cardiovascular disease.
|
Key Features & Benefits
Three minute test procedure
Instant results
Easy-to-use, no specialized training required
Built-in procedural and reagent control line
Up to 18 month shelf-life at 2 - 30 C
High sensitivity and specificity
Whole blood, serum or plasma specimens
No refrigeration required
No timers required
Results are easy to interpret
No specialized equipment required
